Tapoly Ltd

Date authorised
5 February 2018
Companies House
10340563
Last scraped
1 week ago
Watch for changes

Addresses

The contact details this firm has registered with the FCA.

  • Principal Place of Business

    Floor 24/25, The Shard
    32 London Bridge Street
    London
    SE1 9SG
    UNITED KINGDOM
    Phone
    +442078460108
    Web
    https://www.tapoly.com

  • Complaints Contact

    Floor 24/25, The Shard
    32 London Bridge Street
    London
    SE1 9SG
    UNITED KINGDOM
    Phone
    +442078460108

What this firm is allowed to do

The regulated activities the FCA has granted this firm permission to carry out.

  • Investment Advice (no pensions)

    For Commercial, Retail (Non-Investment Insurance), Non-investment insurance contracts

  • Authorised to Operate

    Show 1 limitation
    • · The firm can only agree to carry on the regulated activities specified in this Notice.

  • Arranges Investments

    For Commercial, Retail (Non-Investment Insurance), Non-investment insurance contracts

  • Insurance Admin

    For Commercial, Retail (Non-Investment Insurance), Non-investment insurance contracts

  • Credit Brokering

  • Stockbroking

    For Commercial, Retail (Non-Investment Insurance), Non-investment insurance contracts

  • Investment Setup

    For Commercial, Retail (Non-Investment Insurance), Non-investment insurance contracts

Approved individuals

Senior staff personally approved by the FCA to hold their roles here.

  • ALEXANDER OVIE TAKPI

    IRN AXT91979

    • SMF3 (AR) Executive Director function (since 4 Dec 2025)
  • David Howard Hodgkinson

    IRN DHH01035

    • CF2 Non Executive Director (AR) (since 8 Oct 2021)
  • Jacqueline Cecilia Kilgour

    IRN JCK01083

    • CF2 Non Executive Director (AR) (since 8 Oct 2021)
  • Janthana Kaenprakhamroy

    IRN JXK02162

    • SMF3 Executive Director (since 9 Dec 2019)
    • Responsible for Insurance Distribution (since 1 Oct 2018)
    • Responsible for Insurance Mediation (5 Feb 2018 to 30 Sep 2018)
    • CF8 Apportionment and Oversight (5 Feb 2018 to 8 Dec 2019)
    • CF1 Director (5 Feb 2018 to 8 Dec 2019)
  • Michael John Madoc Jenkins

    IRN MXJ10540

    • CF1 Director (AR) (since 8 Oct 2021)
    • CF3 Chief Executive (AR) (since 8 Oct 2021)
  • Samuel Angus Hopkins

    IRN SAH01324

    • SMF3 Executive Director (9 Dec 2019 to 13 Apr 2026)
    • CF1 Director (5 Feb 2018 to 8 Dec 2019)
  • Thomas Norman O'Brien

    IRN TNO01000

    • CF3 Chief Executive (AR) (since 22 Sep 2021)
    • CF1 Director (AR) (since 22 Sep 2021)

Appointed representatives

Smaller firms operating under this firm's FCA authorisation.

Recent activity

Updates to this firm's record on the FCA register.

No changes recorded yet.